Alembic Pharma

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE901L01018
  • NSEID: APLLTD
  • BSEID: 533573
INR
799.60
-0.8 (-0.1%)
BSENSE

Oct 09

BSE+NSE Vol: 1.93 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 807696,
    "name": "Alembic Pharma",
    "stock_name": "Alembic Pharma",
    "full_name": "Alembic Pharmaceuticals Ltd.",
    "name_url": "stocks-analysis/alembic-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "799.60",
    "chg": -0.8,
    "chgp": "-0.1%",
    "dir": -1,
    "prev_price": "800.40",
    "mcapval": "15,640.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 533573,
    "symbol": "APLLTD",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE901L01018",
    "curr_date": "Oct 09",
    "curr_time": "",
    "bse_nse_vol": "1.93 lacs",
    "exc_status": "Active",
    "traded_date": "Oct 09, 2026",
    "traded_date_str": "2026 10 09",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/alembic-pharma-807696-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Alembic Pharma shares rise 4% on receiving USFDA EIR for Vadodara facility",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-09-17 13:28:46",
        "description": "Alembic Pharma shares rise 4% on receiving USFDA EIR for Vadodara facility  Business Today..."
      },
      {
        "title": "Stock Alert: Tempsens Instruments India, Infosys, Highway Infra, Alembic Pharma",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-09-17 09:04:16",
        "description": "Stock Alert: Tempsens Instruments India, Infosys, Highway Infra, Alembic Pharma  Business Standard..."
      },
      {
        "title": "Stock Alert: Tempsens Instruments India, Infosys, Highway Infra, Alembic Pharma",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-09-17 09:04:16",
        "description": "Stock Alert: Tempsens Instruments India, Infosys, Highway Infra, Alembic Pharma  Business Standard..."
      },
      {
        "title": "Alembic Pharma clears USFDA inspection at Vadodara bioequivalence facility",
        "link": "https://news.google.com/rss/articles/CBMi4AFBVV95cUxQczh4dENReWZLQ1VGM1FTclRzNE15bTc0Ynd6ZFgyMjZtenJpRzNxd29PdFFBVGZLdWpJTV9IUHBLcTd5M1N0T1k1QUtYLVNUNnduMDI2R2lHOFVEbGdwSDFhS2ZPUnJwZVk2bFE5MEZUNHhjei1pYjk0WHFPVEV4WGt2dlhFOWxKQThrZi1scExMeTZFODExTUpPSjZHVmFhT0lDSzhrRkhSTDJBRl8zeEM4YTdkSmd1eEhkVV9VMm9jMXVVMERreGs2YzgtUExiSmNUZDJOUlU5VXBGbjJxTNIB4AFBVV95cUxQczh4dENReWZLQ1VGM1FTclRzNE15bTc0Ynd6ZFgyMjZtenJpRzNxd29PdFFBVGZLdWpJTV9IUHBLcTd5M1N0T1k1QUtYLVNUNnduMDI2R2lHOFVEbGdwSDFhS2ZPUnJwZVk2bFE5MEZUNHhjei1pYjk0WHFPVEV4WGt2dlhFOWxKQThrZi1scExMeTZFODExTUpPSjZHVmFhT0lDSzhrRkhSTDJBRl8zeEM4YTdkSmd1eEhkVV9VMm9jMXVVMERreGs2YzgtUExiSmNUZDJOUlU5VXBGbjJxTA?oc=5",
        "imagepath": "",
        "date": "2026-09-11 14:36:08",
        "description": "Alembic Pharma clears USFDA inspection at Vadodara bioequivalence facility  Business Standard..."
      },
      {
        "title": "Alembic Pharma clears USFDA inspection at Vadodara bioequivalence facility with nil observations",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-09-11 14:05:34",
        "description": "Alembic Pharma clears USFDA inspection at Vadodara bioequivalence facility with nil observations  BusinessLine..."
      }
    ],
    "total": 5,
    "sid": "807696",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/alembic-pharmaceuticals-807696"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "06-Oct-2026",
      "details": "Please find enclosed Certificate under Reg. 74(5) of SEBI (DP) Regulations 2018",
      "source": "BSE"
    },
    {
      "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
      "datetime": "29-Sep-2026",
      "details": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for DSP Trustee Pvt Ltd & Others",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "28-Sep-2026",
      "details": "Please find enclosed Intimation of Trading Window Closure.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Alembic Pharmaceuticals Ltd. has declared <strong>600%</strong> dividend, ex-date: 29 Jul 26",
          "dt": "2026-07-29",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock-recommendationAnnouncement

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

06-Oct-2026 | Source : BSE

Please find enclosed Certificate under Reg. 74(5) of SEBI (DP) Regulations 2018

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011

29-Sep-2026 | Source : BSE

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for DSP Trustee Pvt Ltd & Others

Closure of Trading Window

28-Sep-2026 | Source : BSE

Please find enclosed Intimation of Trading Window Closure.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Alembic Pharmaceuticals Ltd. has declared 600% dividend, ex-date: 29 Jul 26

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available